BIOR
Price
$1.09
Change
-$0.08 (-6.84%)
Updated
Mar 28, 1:55 PM EST
MDGL
Price
$266.43
Change
+$7.62 (+2.94%)
Updated
Mar 28, 2:20 PM EST
40 days until earnings call
Ad is loading...

Analysis and predictions BIOR vs MDGL

Header iconBIOR vs MDGL Comparison
Open Charts BIOR vs MDGLBanner chart's image
Biora Therapeutics
Price$1.09
Change-$0.08 (-6.84%)
Volume$300
CapitalizationN/A
Madrigal Pharmaceuticals
Price$266.43
Change+$7.62 (+2.94%)
Volume$200
CapitalizationN/A
View a ticker or compare two or three
BIOR vs MDGL Comparison Chart

Loading...

BIORDaily Signal changed days agoGain/Loss if shorted
 
Show more...
MDGLDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
BIOR vs. MDGL commentary
Mar 28, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIOR is a StrongSell and MDGL is a StrongBuy.

COMPARISON
Comparison
Mar 28, 2024
Stock price -- (BIOR: $1.10 vs. MDGL: $267.04)
Brand notoriety: BIOR and MDGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BIOR: 56% vs. MDGL: 30%
Market capitalization -- BIOR: $31.83M vs. MDGL: $5.34B
BIOR [@Biotechnology] is valued at $31.83M. MDGL’s [@Biotechnology] market capitalization is $5.34B. The market cap for tickers in the [@Biotechnology] industry ranges from $576.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.64B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIOR’s FA Score shows that 0 FA rating(s) are green whileMDGL’s FA Score has 0 green FA rating(s).

  • BIOR’s FA Score: 0 green, 5 red.
  • MDGL’s FA Score: 0 green, 5 red.
According to our system of comparison, MDGL is a better buy in the long-term than BIOR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BIOR’s TA Score shows that 4 TA indicator(s) are bullish while MDGL’s TA Score has 5 bullish TA indicator(s).

  • BIOR’s TA Score: 4 bullish, 5 bearish.
  • MDGL’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, MDGL is a better buy in the short-term than BIOR.

Price Growth

BIOR (@Biotechnology) experienced а -7.56% price change this week, while MDGL (@Biotechnology) price change was +4.61% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.78%. For the same industry, the average monthly price growth was +4.85%, and the average quarterly price growth was +88.40%.

Reported Earning Dates

BIOR is expected to report earnings on May 15, 2023.

MDGL is expected to report earnings on May 07, 2024.

Industries' Descriptions

@Biotechnology (+4.78% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for BIOR with price predictions.
OPEN
A.I.dvisor published
a Summary for MDGL with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
MDGL($5.34B) has a higher market cap than BIOR($31.8M). MDGL YTD gains are higher at: 11.855 vs. BIOR (-13.333). BIOR has higher annual earnings (EBITDA): -110.65M vs. MDGL (-360.39M). MDGL has more cash in the bank: 634M vs. BIOR (12.6M). BIOR has less debt than MDGL: BIOR (82.4M) vs MDGL (117M). BIOR has higher revenues than MDGL: BIOR (18K) vs MDGL (0).
BIORMDGLBIOR / MDGL
Capitalization31.8M5.34B1%
EBITDA-110.65M-360.39M31%
Gain YTD-13.33311.855-112%
P/E RatioN/AN/A-
Revenue18K0-
Total Cash12.6M634M2%
Total Debt82.4M117M70%
FUNDAMENTALS RATINGS
MDGL: Fundamental Ratings
MDGL
OUTLOOK RATING
1..100
77
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
PROFIT vs RISK RATING
1..100
46
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BIORMDGL
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
75%
Momentum
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
67%
Bearish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 11 days ago
78%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 3 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
76%
View a ticker or compare two or three
Ad is loading...
BIORDaily Signal changed days agoGain/Loss if shorted
 
Show more...
MDGLDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATUS2.620.13
+5.22%
Altice USA
BHVN57.020.73
+1.30%
Biohaven Ltd
AIP7.520.07
+0.94%
Arteris
E31.470.16
+0.51%
ENI SpA
BIVI0.53N/A
+0.47%
BioVie

BIOR and

Correlation & Price change

A.I.dvisor indicates that over the last year, BIOR has been loosely correlated with RVNC. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if BIOR jumps, then RVNC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIOR
1D Price
Change %
BIOR100%
-12.03%
RVNC - BIOR
36%
Loosely correlated
+4.89%
AUPH - BIOR
34%
Loosely correlated
+1.42%
FBRX - BIOR
33%
Loosely correlated
-2.09%
MDGL - BIOR
33%
Poorly correlated
+4.52%
FATE - BIOR
32%
Poorly correlated
+7.00%
More